Question 1

Is Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) has 1 active shortage notice across 1 country (European Union). Status is refreshed daily from official regulatory sources.

Question 2

Why is Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) in shortage?

Accepted Answer

Regulators attribute the current Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

Where does this Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) shortage status

Where Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) is in shortage

Why Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) is in shortage

Frequently asked questions

Get alerted when Novonordisk Insulin (Human Insulin) (Various Short-, Rapid-, Intermediate-, Mixed- And Long-Acting Forms) status changes